Search Results

• • 18 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• High school football and late-life risk of neurodegenerativo syndromes, 1956-1970

  Authors:Pieter H.H. Janssen, Jay Mandrekar, Michelle M. Mielke, J. Eric Ahlskog, Bradley F. Boeve, Keith Josephs, et al.From:Mayo Clinic Proceedings (Vol. 92, Issue 1) Peer-Reviewed

  Jan. 20173,510 words Report 1530LAbstract Objective: To assess whether athletes who played American varsity high school football between 1956 and 1970 have an increased risk of neurodegenerative diseases later in life. Patients and Methods: We...

• Frequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson Disease

  Authors:J. Michael Bostwick, Kathleen A. Hecksel, Susanna R. Stevens, James H. Bower, and J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 84, Issue 4) Peer-Reviewed

  Apr. 20094,425 words Report 1500LOBJECTIVE: To determine the frequency of new-onset compulsive gambling or hypersexuality among regional patients with Parkinson disease (PD), ascertaining the relationship of these behaviors to PD drug use. PATIENTS...

• New concepts in the treatment of Parkinson's disease

  Authors:J. Eric Ahlskog and John M. WilkinsonFrom:American Family Physician (Vol. 41, Issue 2) Peer-Reviewed

  Feb. 1990235 words Article

   Citation Only

• Erectile Dysfunction Preceding Clinically Diagnosed [alpha]-Synucleinopathies: A Case-Control Study in Olmsted County

  Authors:Shemonti Hasan, Michelle M. Mielke, J. Eric Ahlskog, James Bower, Pierpaolo Turcano, and Rodolfo SavicaFrom:Parkinson's DiseasePeer-Reviewed

  Apr. 30, 20193,850 words Article 1210LObjective. Autonomic symptoms are common in [alpha]-synuclein disorders: multiple system atrophy (MSA), Parkinson's disease (PD), dementia with Lewy bodies (DLB), and Parkinson's disease with dementia (PDD). These...

• High School Football and Risk of neurodegeneration: a community-based study

  Authors:Rodolfo Savica, Joseph E. Parisi, Lester E. Wold, Keith A. Josephs, and J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 87, Issue 4) Peer-Reviewed

  Apr. 20123,726 words Report 1520LAbstract Objective: To assess whether high school football played between 1946 and 1956, when headgear was less protective than today, was associated with development of neurodegenerative diseases later in life....

• My Treatment Approach to Multiple System Atrophy.

  Authors:Elizabeth A. Coon and J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 96, Issue 3) Peer-Reviewed

  Mar. 20216,680 words Report 1380LAbstract Multiple system atrophy (MSA) is a neurodegenerative disorder primarily characterized by autonomic failure plus parkinsonism or cerebellar ataxia. The diagnosis may be challenging and is usually made at a...

• Common Myths and Misconceptions That Sidetrack Parkinson Disease Treatment, to the Detriment of Patients.

  Author:J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 95, Issue 10) Peer-Reviewed

  Oct. 20206,213 words Report 1440LAbstract Parkinson disease symptoms become apparent when there has been substantial loss of brain dopamine. That is the consequence of the slow progression of the Lewy body neurodegenerative process. Replenishment of...

• Calf venous compliance in multiple system atrophy

  Authors:A. Lipp, P. Sandroni, J. Eric Ahlskog, D.M. Maraganore, C.W. Shults, and P.A. LowFrom:American Journal of Physiology (Consolidated) (Vol. 293, Issue 1) Peer-Reviewed

  July 2007277 words Author abstract

   Abstract Only

• Parkinson disease treatment in hospitals and nursing facilities: avoiding pitfalls

  Author:J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 89, Issue 7) Peer-Reviewed

  July 20144,330 words Report 1280LAbstract The unique needs of patients with Parkinson disease challenge staff when such patients are admitted to hospitals or nursing facilities. Prolongation of the hospital stay, falls with injuries, fainting, or...

• Beyond Parkinson Disease: Amyotrophic Lateral Sclerosis and the Axon Guidance Pathway

  Authors:Timothy G. Lesnick, Eric J. Sorenson, J. Eric Ahlskog, John R. Henley, Lina Shehadeh, Spiridon Papapetropoulos, et al.From:PLoS ONE (Vol. 3, Issue 1) Peer-Reviewed

  Jan. 16, 20088,259 words Article 1420LBackground We recently described a genomic pathway approach to study complex diseases. We demonstrated that models constructed using single nucleotide polymorphisms (SNPs) within axon guidance pathway genes were...

• Treatment of motor complications in advancing Parkinson's disease: Which drugs and when?

  Author:J. Eric AhlskogFrom:Formulary (Vol. 35, Issue 8) Peer-Reviewed

  Aug. 20006,046 words Article ABSTRACT After several years of Parkinson's disease (PD), most levodopa-treated patients begin to experience motor complications, ie, clinical fluctuations and dyskinesias. The motor fluctuations relate to the...

• Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging

  Authors:J. Eric Ahlskog, Yonas E. Geda, Neill R. Graff-Radford, and Ronald C. PetersenFrom:Mayo Clinic Proceedings (Vol. 86, Issue 9) Peer-Reviewed

  Sept. 20118,119 words Report 1960LA rapidly growing literature strongly suggests that exercise, specifically aerobic exercise, may attenuate cognitive impairment and reduce dementia risk. We used PubMed (keywords exercise and cognition) and manuscript...

• Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests

  Authors:Valeria Iodice, Axel Lipp, J. Eric Ahlskog, Paola Sandroni, Robert D. Fealey, Joseph E. Parisi, et al.From:Journal of Neurology, Neurosurgery and Psychiatry (Vol. 83, Issue 4) Peer-Reviewed

  Apr. 2012 Clinical report

   Citation Only

• Increased risk of depressive and anxiety disorders in relatives of patients with parkinson disease

  Authors:Gennarina Arabia, Brandon R. Grossardt, Yonas E. Geda, Justin M. Carlin, James H. Bower, J. Eric Ahlskog, et al.From:Archives of General Psychiatry (Vol. 64, Issue 12) Peer-Reviewed

  Dec. 2007 Survey

   Citation Only

• Survival and Progression in Synucleinopathy Phenotypes With Parkinsonism: A Population-Based Study.

  Authors:Rodolfo Savica, Pierpaolo Turcano, James H. Bower, J. Eric Ahlskog, and Michelle M. MielkeFrom:Mayo Clinic Proceedings (Vol. 94, Issue 9) Peer-Reviewed

  Sept. 20193,696 words Article 1660LAbstract Objective: To compare survival by the presenting parkinsonism symptoms at diagnosis among patients with incident clinically diagnosed synucleinopathies. Patients and Methods: Using the Rochester Epidemiology...

• Cheaper, simpler, and better: Tips for treating seniors with parkinson disease

  Author:J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 86, Issue 12) Peer-Reviewed

  Dec. 20114,390 words Report 1400LOn completion of this article, you should be able to (1) formulate an initial medication plan for patients with Parkinson disease, (2) understand the rationale for treating levodopa-associated motor fluctuations and...

• Aerobic Exercise: Evidence for a Direct Brain Effect to Slow Parkinson Disease Progression

  Author:J. Eric AhlskogFrom:Mayo Clinic Proceedings (Vol. 93, Issue 3) Peer-Reviewed

  Mar. 201810,010 words Report 1670LAbstract No medications are proven to slow the progression of Parkinson disease (PD). Of special concern with longer-standing PD is cognitive decline, as well as motor symptoms unresponsive to dopamine replacement...

• Speech and language disorders associated with corticobasal degeneration

  Authors:Margaret Lehman Blake, Joseph R. Duffy, Bradley F. Boeve, Eric J. Ahlskog, and Demetrius M. MaraganoreFrom:Journal of Medical Speech - Language Pathology (Vol. 11, Issue 3) Peer-Reviewed

  Sept. 20038,238 words Article Corticobasal degeneration (CBD) is a neurodegenerative disease characterized by asymmetric cortical and extrapyramidal signs including progressive asymmetric limb rigidity and apraxia. Other commonly occurring signs...